Attorneys Brent Babcock and Rick Park authored “The Legal Battle Around CRISPR Gene-Editing Technology and Its Implications,” which was published in Biotechnology Law Report. The article describes the CRISPR-Cas9 technology, a brief history of how the technology was developed, the implication of the technology, and summarizes the Patent Trial and Appeal Board’s (PTAB) recent decision affecting the patent rights over the technology.
Read the full article on the Biotechnology Law Report website >> (subscription required)